Comp (SBS) Competitor Comparison
We are evaluating the key criteria listed to compare Comp (SBS) against its competitors in the Biotechnology industry.
Market Capitalization
16 / 368Gross Profits
109 / 278Total Revenue
198 / 300EBITDA
117 / 337Free Cashflow
123 / 352Quick Ratio
124 / 357Earnings per Share
23 / 359Dividend yield
5 / 6Total Cash
218 / 358Performance 3 years
42 / 368Performance 5 years
123 / 368Performance 10 years
52 / 368Linearity 3 years
165 / 368Linearity 5 years
25 / 368Linearity 10 years
275 / 367Total Rank
2 / 368Dividend Rank
3 / 368Valuation Rank
38 / 368Piotroski Rank
3 / 368Muliplier Rank
14 / 368Market Capitalization - SBS ranking 16 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.